NASDAQ · Stocky rates: Hold

CME Group Inc. (CME)

$270.03 ▲ +2.62% as of 5 Oct, 20:00

Stocky turns companies like CME Group Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
69
/ 100
Hold

What Stocky thinks

Stocky rates CME Group Inc. at 69/100 based on business quality, leadership alignment, valuation.

Compounder Score
59/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
60/100
Founder-led, insider ownership, capital allocation history.
Moat Score
83/100
Competitive advantage — pricing power, switching costs, network effects.
Resilience
100/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
59/100
Valuation vs peers and history — is this a good price to pay?
Analyst Sentiment
53/100
Top analysts' conviction — buy/hold/sell distribution + track record.

Not graded: for banks, insurers and brokers, borrowing and taking deposits is the business itself, so the usual debt checks don't apply.

What Stocky gives investors that other tools don't

Every stock is scored across six dimensions built to answer one question — can this business keep compounding? — without a Bloomberg subscription. Here's the actual snapshot for CME Group Inc.:

69
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation fused into a single 0–100 number. When you see 69/100, you know instantly whether to dig deeper or skip.

Wide
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

60
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

100
RESILIENCE

Resilience Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

We don't claim a backtest. The top-scoring basket is recorded every month and measured against the S&P 500 from that date onward — judged on what it said before the outcome was known. The record is young, and published as it stands.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

CME Group Inc. (CME) — frequently asked

Is CME Group Inc. (CME) a good investment right now?

Stocky rates CME Group Inc. (CME) at 69/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation into a single number.

What is CME's Stocky Verdict?

CME's current Stocky Verdict is 69/100, placing it in the "Hold" band. This composite combines a 59/100 Compounder score, 60/100 Leadership, 83/100 Moat rating.

Does CME Group Inc. have a competitive moat?

CME Group Inc. rates Wide moat (83/100 Moat Score) — based on 10-year return-on-invested-capital, pricing power, switching costs and network effects. Wide moats compound; Limited moats erode.

Is CME Group Inc.'s leadership aligned with shareholders?

CME Group Inc. scores 60/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to CME?

CME Group Inc.'s Resilience Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to CME Group Inc..

This is just the surface. See the whole picture on CME Group Inc..

Sign up free and unlock the full analysis on CME — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering CME — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Resilience Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for CME.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how CME changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to CME?" · "Is CME overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
69
/ 100 · Hold

See CME Group Inc. the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in CME would be worth today.
Practice portfolio
Buy CME with virtual money and track it — zero risk.
Free · no real money · learn by doing Open CME in Stocky →

Or jump straight to the interactive dashboard for CME in the app.